Clinical Trials Directory

Trials / Completed

CompletedNCT01597427

Reduction of Pulmonary Artery Pressure in Patients Subjected to Cardiac Surgery

Intravenous Clonidine Does Not Reduce Pulmonary Artery Pressure in Patients Subjected to Cardiac

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
29 (actual)
Sponsor
Federal University of São Paulo · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to assess the ability of clonidine to reduce the mean pulmonary artery pressure in patients with pulmonary hypertension subjected to cardiac surgery.

Detailed description

Prospective, clinical-interventionist, randomized, and double-blind study. Patients with group 2 pulmonary hypertension will be included and subjected to cardiac surgery with extracorporeal circulation. Mean pulmonary artery pressure and the doses of dobutamine and sodium nitroprusside will be assessed four times: before (T0) administration of 2 μg/kg of intravenous clonidine or a placebo, 30 minutes after the onset of treatment (T1), immediately after extracorporeal circulation (T2), and 10 minutes after the injection of protamine (T3).

Conditions

Interventions

TypeNameDescription
DRUGClonidineAdministration of 2 μg/kg of intravenous clonidine
DRUGPlaceboInjection of placebo solution.

Timeline

Start date
2009-03-01
Primary completion
2011-04-01
Completion
2012-03-01
First posted
2012-05-14
Last updated
2012-05-14

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01597427. Inclusion in this directory is not an endorsement.